HCM
CELG

Highbridge Capital Management’s Celgene Corp CELG Stock Holding History

Highbridge Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-500,000
Closed -$47.2M – 375
2019
Q1 		$47.2M Buy
+500,000
New +$43.7M 1.45% 9
2018
Q3 		– Sell
-2,500
Closed -$200K – 1048
2018
Q2 		$200K Buy
2,500
+100
+4% +$8.3K ﹤0.01% 829
2018
Q1 		$215K Sell
2,400
-17,600
-88% -$1.69M ﹤0.01% 1031
2017
Q4 		$2.08M Buy
20,000
+17,200
+614% +$1.94M 0.04% 384
2017
Q3 		$412K Buy
+2,800
New +$381K 0.01% 1045
2016
Q3 		– Sell
-14,200
Closed -$1.4M – 1937
2016
Q2 		$1.4M Sell
14,200
-13,400
-49% -$1.39M 0.02% 523
2016
Q1 		$2.76M Buy
27,600
+20,100
+268% +$2.07M 0.05% 435
2015
Q4 		$899K Buy
+7,500
New +$868K 0.01% 791
2014
Q4 		– Sell
-3,100
Closed -$293K – 1678
2014
Q3 		$293K Buy
+3,100
New +$280K ﹤0.01% 1006
2013
Q4 		– Sell
-10,200
Closed -$786K – 1604
2013
Q3 		$786K Sell
10,200
-13,200
-56% -$925K 0.01% 740
2013
Q2 		$1.37M Buy
+23,400
New +$1.41M 0.01% 580

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Highbridge Capital Management's CELG Position: Q2 2019 in Review

Highbridge Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 187,065 shares — an estimated $17.6M sold.

Highbridge Capital Management first reported a position in CELG in Q2 2013 and held it in 17 quarters. The position peaked at $53.6M in Q1 2014. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Highbridge Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Highbridge Capital Management sold 187,065 Celgene Corp shares in Q2 2019, an estimated $17.6M.
  • Highbridge Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 17 quarters.
  • Highbridge Capital Management's Celgene Corp position peaked at $53.6M in Q1 2014.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Highbridge Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.